RE: CA 19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Preoperative Therapy

Bold, Richard
July 2013
Annals of Surgical Oncology: An Oncology Journal for Surgeons;Jul2013, Vol. 20 Issue 7, p2108
Academic Journal
No abstract available.


Related Articles

  • Long Term Complete Response of Unresectable Locally Advanced Pancreatic Cancer after CCRT and Gemcitabine Chemotherapy. Jaeyun Yang; Taekyu Lim; Taegyoon Kim; Seungmoon Han; Sanghee Lee; Huiseo Kim; Jiwon Lee; Seongyeong Ahn // Korean Journal of Pancreas & Biliary Tract;Oct2016, Vol. 21 Issue 4, p209 

    Locally advanced or metastatic disease accounts for two thirds of total patients with pancreatic cancer. Patients with pancreatic cancer are assessed as resectable, potentially resectable (borderline) or unresectable according to pre-operative examinations. The chances of resectability may be...

  • Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. DeWitt, John; Devereaux, Benedict; Chriswell, Melissa; McGreevy, Kathleen; Howard, Thomas; Imperiale, Thomas F.; Ciaccia, Donato; Lane, Kathleen A.; Maglinte, Dean; Kopecky, Kenyon; LeBlanc, Julia; McHenry, Lee; Madura, James; Aisen, Alex; Cramer, Harvey; Cummings, Oscar; Sherman, Stuart // Annals of Internal Medicine;11/16/2004, Vol. 141 Issue 10, p753 

    Background: Accurate preoperative detection and staging of pancreatic cancer may identify patients with locoregional disease that is amenable to surgical resection. Objective: To compare endoscopic ultrasonography and multidetector computed tomography (CT) for the...

  • Neoadjuvant Therapy of Pancreatic Cancer: The Emerging Paradigm? LIM, KIAN-HUAT; CHUNG, EUGENE; KHAN, ADEEL; CAO, DENGFENG; LINEHAN, DAVID; BEN-JOSEF, EDGAR; WANG-GILLAM, ANDREA // Oncologist;Feb2012, Vol. 17 Issue 2, p192 

    Pancreatic cancer remains one of the deadliest cancers due to difficulty in early diagnosis and its high resistance to chemotherapy and radiation. It is now clear that even patients with potentially resectable disease require multimodality treatment including chemotherapy and/or radiation to...

  • Pancreatic Cancer - Surgical Progress and Future Management. Ecker, Brett L.; Chu, Edward W.; Garg, Malika; Divino, Celia M. // Journal of Surgical Radiology;Oct2012, Vol. 3 Issue 4, p244 

    Purpose Deaths from pancreatic ductal adenocarcinoma rank fourth among cancer-related mortality in the United States. Curative resection is the single most important factor determining survival in patients with pancreatic adenocarcinoma. This review explores the surgical management of pancreatic...

  • Neoadjuvant therapy for pancreatic cancer. Lowy, Andrew M. // Journal of Gastrointestinal Surgery;Sep2008, Vol. 12 Issue 9, p1600 

    Surgical resection is necessary but generally insufficient as curative treatment for pancreatic cancer. Traditionally, postoperative (adjuvant) therapies have been utilized in an attempt to improve outcome, yet these efforts have met with extremely limited success. As preoperative (neoadjuvant)...

  • Pankreaskarzinom im hohen Alter. NieƟ, H.; Kleespies, A.; Andrassy, J.; Pratschke, P.; Angele, M.K.; Guba, M.; Jauch, K.-W.; Bruns, C.J. // Der Chirurg;Apr2013, Vol. 84 Issue 4, p291 

    The considerable increase of the aged population in western civilisation within the next years will result in a rising incidence of pancreatic cancer. Until the year 2020 an increment of 20 % of patients beyond 65 years old can be anticipated. Therefore, the focus will be on management of old...

  • Preoperative biliary stents in pancreatic cancer. Bonin, Eduardo; Baron, Todd // Journal of Hepato -- Biliary -- Pancreatic Sciences;Sep2011, Vol. 18 Issue 5, p621 

    Background: Pancreatic cancer is a common digestive cancer with high mortality, and surgical resection is the only potential curative treatment option. Pancreatic head cancer is usually accompanied by biliary obstruction, which potentially increases surgical complications following...

  • A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic cancer. Eloubeidi, Mohamad A.; Varadarajulu, Shyam; Desai, Shilpa; Shirley, Rhett; Heslin, Martin J.; Mehra, Mohit; Arnoletti, Juan P.; Eltoum, Isam; Wilcox, Charles M.; Vickers, Selwyn M. // Journal of Gastrointestinal Surgery;Jul2007, Vol. 11 Issue 7, p813 

    Background: Whether tissue diagnosis is required in the preoperative evaluation of patients with suspected pancreatic cancer remains controversial. We prospectively evaluated the accuracy, safety, and potential impact on surgical intervention of endoscopic ultrasound-guided fine...

  • Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. Duffy, M. J.; Sturgeon, C.; Lamerz, R.; Haglund, C.; Holubec, V. L.; Klapdor, R.; Nicolini, A.; Topolcan, O.; Heinemann, V. // Annals of Oncology;Mar2010, Vol. 21 Issue 3, p441 

    Pancreatic ductal adenocarcinoma is one of the most difficult malignancies to diagnose and treat. The aim of this article is to review how tumor markers can aid the diagnosis and management of patients with this malignancy. The most widely used and best validated marker for pancreatic cancer is...

  • Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer). YOSHIMURA, KIYOSHI; OLINO, KELLY; EDIL, BARISH H.; SCHULICK, RICHARD D.; OKA, MASAAKI // Surgery Today;May2010, Vol. 40 Issue 5, p404 

    Current treatment modalities of surgical resection and chemotherapy against cancers have improved survival. However, mortality from tumor recurrence remains high. Immunotherapy and gene therapy are potential additions to the treatment arsenal in the care of cancer patients. These novel...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics